UnitedHealth Provides 2012 Guidance - Analyst Blog
November 29 2011 - 11:30AM
Zacks
On Monday, through a brief press release, health insurer
UnitedHealth Group Inc. (UNH)
announced its earnings outlook for the full year 2012. The company
expects the earnings to be in the range of $4.55 to $4.75. It also
affirmed its 2011 full year guidance of $4.52 to $4.57.
While the upper range of UnitedHealth’s 2012 earnings guidance
is in tune with the Zacks Consensus Estimate, its 2011 guidance is
meeting the Zacks Consensus Estimate of $4.55, at the midpoint
range.
UnitedHealth, the largest insurer on the basis of revenue, also
expects its 2012 revenues in the range of $107.0 billion to $108.0
billion, up approximately 6.5% from the 2011 revenue guidance of
more than $101 billion. The 2012 EPS guidance reflects a 2.2% of
year-over-year increase (calculated at the mid-point range).
We expect the company to easily achieve the targets based on its
strong operating fundamentals. In fact, UnitedHealth has had a
tradition of guiding conservatively and then beating the estimates
to surprising investors.
The latest guidance does not include any earnings accretion from
UnitedHealth’s recent acquisition of XL Health Corp., neither does
it incorporate any estimate of cost from the pending Penn Treaty
matter. However, as management previously commented that the
acquisition is slated to close in the first half of 2012, and is
expected to add to EPS, we will not be surprised to see the company
delivering substantially better-than-expected results.
Other factors that are expected to boost 2012 earnings
include:
Leading position in the Medicare business: UnitedHealth
enjoys a high exposure in the Medicare market, which is expected to
boom in the coming years as million of Americans will enter the
retirement age. Moreover, with the acquisition of XLHealth, the
company will further strengthen its position in the MA market,
compelling long-term growth.
Fast-growing Health Services segment: This business,
branded under the name Optum, boasts of higher margin and is a very
important part of the company’s diversification strategy. For the
nine months ended September 30, 2011, the segment delivered
approximately 18% growth. Now with the expansion of the health
service business, management expects the revenue contribution to
approximately double over time.
Strong balance sheet: The insurer enjoys a solid
balance sheet with adequate financial flexibility and a favorable
debt ratio, which helps it make decisions on acquisitions easily.
Moreover, UnitedHealth has opted for shareholder-friendly measure
for managing capital such as dividend payment and buying back
shares. Last year, the company raised its dividend to 50 cents from
3 cents, making it the biggest hike in the industry.
However, some of the factors that may partially offset the above
positives include higher than expected medical cost and weaker
membership enrollment.
Among UnitedHealth’s peers, Aetna Inc. (AET)
and Humana Inc. (HUM) also provided guidance for
2012. Aetna expects earnings to be at least $4.80 per share, while
Humana sounded more specific, guiding 2012 EPS in the range of
$7.40 to $7.60 per share.
UnitedHealth currently retains a Zacks #3 Rank, which translates
into a short-term Hold rating. However, considering the
fundamentals, we are maintaining our long-term Outperform
recommendation on the shares.
AETNA INC-NEW (AET): Free Stock Analysis Report
HUMANA INC NEW (HUM): Free Stock Analysis Report
UNITEDHEALTH GP (UNH): Free Stock Analysis Report
Zacks Investment Research
Aetna (NYSE:AET)
Historical Stock Chart
From Apr 2024 to May 2024
Aetna (NYSE:AET)
Historical Stock Chart
From May 2023 to May 2024